Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: maceng2 who wrote (179522)	10/20/2021 9:37:44 AM
From: ggersh	1 Recommendation Recommended By maceng2 Respond to of 219150

The EU, back to the "Dark Ages" So it turns out that, in a bid to hold on to power, Bolivian dictator Jeanine Añez paid Colombian mercenaries to kill her political opponent days before the 2020 election. She's just been nominated for the EU Parliment's highest human rights award. 🙃🇧🇴https://t.co/29Vhoxeg7G pic.twitter.com/JqbXUR2ULj — Alan MacLeod (@AlanRMacLeod) October 19, 2021

To: maceng2 who wrote (179522)	10/20/2021 11:48:31 AM
From: ggersh	2 Recommendations Recommended By maceng2 marcher Read Replies (1) \| Respond to of 219150

Money, money, money,.....money childrenshealthdefense.org ‘Unconscionable’: Pfizer, Moderna to Rake in Combined $93 Billion in 2022 COVID Vaccine Sales A report by health data analytics group, Airfinity, projects “unprecedented” sales and profits for Pfizer and Moderna in 2022. According to the People’s Vaccine Alliance, the companies are pricing their vaccines by as much as $41 billion above the estimated cost of production.